Researcher Next
Create account
← Back to directory

Nir Peled

Researcher Next ID · RN-010929

Researcher · Medicine

Hebrew University of Jerusalem

, Israel

Sign in to saveSign in to claim
Not currently recruitingFunding unknown
Works count
552
Citation count
44,289
H-index
76
i10-index
229

Research interests

Medicine
Biochemistry, Genetics and Molecular Biology
Lung Cancer Treatments and Mutations
Lung Cancer Diagnosis and Treatment
Cancer Immunotherapy and Biomarkers
Lung Cancer Research Studies
Cancer Genomics and Diagnostics

Publications

  • Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater

    Journal of Clinical Oncology · 2019 · 10.1200/jco.18.00149

  • Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry

    Annals of Oncology · 2019 · 10.1093/annonc/mdz167

  • Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer

    New England Journal of Medicine · 2018 · 10.1056/nejmoa1801005

  • STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS -Mutant Lung Adenocarcinoma

    Cancer Discovery · 2018 · 10.1158/2159-8290.cd-18-0099

  • Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer

    New England Journal of Medicine · 2016 · 10.1056/nejmoa1606774

Current projects

    No projects listed.